That's a really important question, and it's great that you're staying on top of your detailed blood work! An MPL mutation at 1.2% (a low allele burden) combined with a platelet count of 478 is worth discussing closely with your hematologist.
A platelet count of 478 is only mildly above the normal range of (Phone number can Show Full Answer
That's a really important question, and it's great that you're staying on top of your detailed blood work! An MPL mutation at 1.2% (a low allele burden) combined with a platelet count of 478 is worth discussing closely with your hematologist.
A platelet count of 478 is only mildly above the normal range of (Phone number can only be seen by the question and answer creators). This is considered a modest elevation. When it comes to whether Hydroxyurea is necessary, doctors typically weigh several factors before recommending it:
- Your age — older patients carry higher risk
- Prior blood clots or thrombotic events — a history increases risk
- Your mutation type — MPL mutations are generally considered less thrombogenic (clot-causing) than JAK2 mutations
- Your symptoms — whether you're experiencing complications matters greatly
The good news is that MPL mutations carry a lower blood clot risk compared to JAK2 mutations, which may influence your doctor's approach. Many people with mildly elevated platelets and lower-risk profiles are managed with a "watch and wait" approach, sometimes alongside low-dose aspirin rather than Hydroxyurea. Doctors often focus less on the number itself and more on what it means for your overall health and risk profile.
This is absolutely a conversation to have with your hematologist, as they'll assess your full picture before recommending treatment.
November 2
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
